Aprea Therapeutics, Inc. ($APRE)
Filing Information
| Accession Number | 0001104659-26-009203 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 2, 2026 |
| Document Date | Jan 30, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
11,400
Total Value
$5,073.00
P&L
-14.4% ($728.46)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SrVP/CFO/Prin Fin & Acct Ofcr | Common Stock | โ | Jan 30, 2026 | Purchase | 5,700 | $0.89 | $5,073.00 | 33,433 | Direct | โ | View Details | |
SrVP/CFO/Prin Fin & Acct Ofcr | Common Warrant | Derivative | Jan 30, 2026 | Purchase | 5,700 | โ | โ | 5,700 | Direct | โ | View Details |